Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

CACNA1H antibody (Intracellular)

KO Validated CACNA1H Reactivity: Rat WB, IHC, IP, IF, IC Host: Rabbit Polyclonal unconjugated
Catalog No. ABIN7043010
  • Target See all CACNA1H Antibodies
    CACNA1H (Calcium Channel, Voltage-Dependent, T Type, alpha 1H Subunit (CACNA1H))
    Binding Specificity
    • 12
    • 5
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 581-595, Intracellular
    Reactivity
    • 34
    • 17
    • 16
    Rat
    Host
    • 21
    • 17
    Rabbit
    Clonality
    • 21
    • 17
    Polyclonal
    Conjugate
    • 19
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    This CACNA1H antibody is un-conjugated
    Application
    • 26
    • 20
    • 18
    • 13
    • 13
    • 10
    • 9
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunofluorescence (IF), Immunochromatography (IC)
    Purpose
    A Rabbit Polyclonal Antibody to CaV3.2 (CACNA1H) Channel
    Specificity
    Intracellular loop between domains D1 and D2
    Cross-Reactivity
    Human, Mouse, Rat
    Predicted Reactivity
    Mouse, human - 13,canis - 14,bovine,15 amino acid residues identical
    Characteristics
    Anti-CaV3.2 (CACNA1H) Antibody (ABIN7043010, ABIN7043980 and ABIN7043981)) is a highly specific antibody directed against an epitope of the rat protein. The antibody can be used in western blot, immunoprecipitation, immunohistochemistry, and immunocytochemistry applications. It has been designed to recognize CaV3.2 from rat, human, and mouse samples.
    Purification
    Affinity purified on immobilized antigen.
    Grade
    KO Validated
    Immunogen

    Immunogen: Synthetic peptide

    Immunogen Sequence: CHVEGPQERARVAHS, corresponding to amino acid residues 581-595 of rat CaV3.2

    Isotype
    IgG
    Top Product
    Discover our top product CACNA1H Primary Antibody
  • Application Notes

    Antigen preadsorption control: 1 μg peptide per 1 μg antibody

    Application Dilutions Immunohistochemistry paraffin embedded sections ihc: 1:50-1:100

    Application Dilutions Western blot wb: 1:200

    Comment

    Cited Application: IP|IHC|ICC

    Negative Control: BLP-CC025

    Blocking Peptide: BLP-CC025

    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Reconstitution
    Recosntitute with double distilled water (DDW) to a concentration of 1.0 mg/mL.
    Concentration
    1 mg/mL
    Buffer
    PBS pH 7.4
    Storage
    4 °C,-20 °C
    Storage Comment

    Storage before reconstitution: The antibody ships as a lyophilized powder at room temperature. Upon arrival, it should be stored at -20°C.

    Storage after reconstitution: The reconstituted solution can be stored at 4°C for up to 1 week. For longer periods, small aliquots should be stored at -20°C. Avoid multiple freezing and thawing. Centrifuge all antibody preparations before use (10000 x g 5 min).

  • Target
    CACNA1H (Calcium Channel, Voltage-Dependent, T Type, alpha 1H Subunit (CACNA1H))
    Alternative Name
    CACNA1H (CACNA1H Products)
    Background
    Voltage-dependent T-type calcium channel subunit α1H,T-type Ca2+ channels play an important role in many cellular processes such as hormone secretion, neurotransmitter release and cell differentiation. T-type channels are also known to participate in the pacemaker activities of the heart and neurons including thalamic neurons.1Three genes encoding T-type Ca2+ channels have been cloned and designated as CaV3.2 (CACNA1H), CaV3.1 (CACNA1G) and CaV3.3 (CACNA1I).1-3 The CaV3.2 channel is widely expressed in various tissues such as the brain, heart, liver and testis.Involvement of CaV3.2 Ca2+ channels in several pathologies has been described. Overexpression of the CaV3.2 channel was described in prostate cancer cells that are associated with more aggressiveness, invasiveness and poor prognosis.4 Several point mutations discovered in the CaV3.2 channel that affect gating of the channel were found to be associated with Childhood Absence Epilepsy.5 One year old mice, deficient in CaV3.2 channel, exhibited severe cardiac pathology, fibrosis, necrosis, lymphocyte infiltration and abnormal coronary function compared to wild-type mice.6 Recently, it has been demonstrated that T-type channels are expressed in DRG neurons and that small and medium-diameter primary afferent neurons in the dorsal horn expresses almost exclusively the CaV3.2 Ca2+channels. This might indicate a possible role for CaV3.2 in nociception.7

    Alternative names: Cav3.2, alpha1H (T-Type)
    Gene ID
    114862
    NCBI Accession
    NM_001005407
    UniProt
    Q9EQ60
    Pathways
    C21-Steroid Hormone Metabolic Process
You are here:
Support